<DOC>
	<DOC>NCT02144389</DOC>
	<brief_summary>Randomized Controlled Trial: The investigational materials used in this trial were administered to subjects each day by trained clinicians. Primary Objectives: - assess the effect of dietary supplementation with arachidonic acid on the cure rates for Schistosomiasis mansoni with and without concomitant treatment with praziquantel. - assess the safety of dietary supplementation using arachidonic acid in children with clinically confirmed schistosomiasis mansoni infection. Secondary objective: - to measure changes in total phospholipids in plasma.</brief_summary>
	<brief_title>Arachidonic Acid Treatment Against Schistosomiasis Infection in Children</brief_title>
	<detailed_description />
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>consent from parent or legal guardian clinically confirmed schistosomiasis not infected with schistosomiasis less than 6 or greater than 15 years of age</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Arachidonic acid</keyword>
	<keyword>Bilharzia</keyword>
	<keyword>Mansoni</keyword>
	<keyword>Schistosomiasis</keyword>
	<keyword>Polyunsaturated fatty acid</keyword>
</DOC>